相似文献
1
Adeno-associated virus-mediated cancer gene therapy: current status.
Cancer Lett. 2015 Jan 28;356(2 Pt B):347-56. doi: 10.1016/j.canlet.2014.10.045. Epub 2014 Nov 10.
2
Cancer gene therapy using adeno-associated virus vectors.
Front Biosci. 2008 Jan 1;13:2653-9. doi: 10.2741/2872.
3
Vectrology of adeno-associated viruses (AAV).
Med Wieku Rozwoj. 2013 Jul-Sep;17(3):202-6.
4
The Adeno-associated Virus - A Safe and Promising Vehicle for Liverspecific Gene Therapy of Inherited and Non-inherited Disorders.
Curr Gene Ther. 2017;17(1):4-16. doi: 10.2174/1566523217666170314141931.
5
Adeno-associated virus vectors: potential applications for cancer gene therapy.
Cancer Gene Ther. 2005 Dec;12(12):913-25. doi: 10.1038/sj.cgt.7700876.
6
Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
Cancer Lett. 2009 Dec 28;286(2):196-205. doi: 10.1016/j.canlet.2009.05.024. Epub 2009 Jun 28.
7
Orthopaedic gene therapy using recombinant adeno-associated virus vectors.
Arch Oral Biol. 2011 Jul;56(7):619-28. doi: 10.1016/j.archoralbio.2010.12.010. Epub 2011 Feb 26.
8
Gene therapy using adeno-associated virus vectors.
Clin Microbiol Rev. 2008 Oct;21(4):583-93. doi: 10.1128/CMR.00008-08.
9
Viral vector-mediated gene therapies.
Curr Opin Neurol. 2015 Oct;28(5):522-7. doi: 10.1097/WCO.0000000000000241.
10
Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
Clin Neurosci. 1995;3(5):292-300.
引用本文的文献
1
LMO7 drives profibrotic fibroblast polarization and pulmonary fibrosis in mice through TGF-β signalling.
Acta Pharmacol Sin. 2025 Feb 25. doi: 10.1038/s41401-025-01488-9.
2
Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma.
ACS Omega. 2024 Jul 3;9(28):30945-30953. doi: 10.1021/acsomega.4c03949. eCollection 2024 Jul 16.
3
Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies.
Vaccines (Basel). 2024 Jun 7;12(6):636. doi: 10.3390/vaccines12060636.
4
CRISPR/Cas9: an overview of recent developments and applications in cancer research.
Int J Surg. 2024 Oct 1;110(10):6198-6213. doi: 10.1097/JS9.0000000000001081.
5
Inducible caspase 9-mediated suicide gene therapy using AAV6 vectors in a murine model of breast cancer.
Mol Ther Methods Clin Dev. 2023 Nov 24;31:101166. doi: 10.1016/j.omtm.2023.101166. eCollection 2023 Dec 14.
6
Engineering siRNA therapeutics: challenges and strategies.
J Nanobiotechnology. 2023 Oct 18;21(1):381. doi: 10.1186/s12951-023-02147-z.
7
A dual role for adeno-associated virus in human health.
Virol J. 2023 Oct 10;20(1):228. doi: 10.1186/s12985-023-02196-8.
8
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine.
Genes Dis. 2023 Mar 25;11(1):268-282. doi: 10.1016/j.gendis.2023.02.027. eCollection 2024 Jan.
9
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview.
Cells. 2023 Mar 1;12(5):785. doi: 10.3390/cells12050785.
10
Adding recombinant AAVs to the cancer therapeutics mix.
Mol Ther Oncolytics. 2022 Oct 2;27:73-88. doi: 10.1016/j.omto.2022.09.009. eCollection 2022 Dec 15.
本文引用的文献
1
The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson's disease.
Pharmacol Rep. 2014 Aug;66(4):660-9. doi: 10.1016/j.pharep.2014.03.008. Epub 2014 Apr 8.
2
Ibrutinib resistance in chronic lymphocytic leukemia.
N Engl J Med. 2014 Jun 12;370(24):2352-4. doi: 10.1056/NEJMc1402716. Epub 2014 May 28.
3
Convection-enhanced delivery of AAV2-PrPshRNA in prion-infected mice.
PLoS One. 2014 May 27;9(5):e98496. doi: 10.1371/journal.pone.0098496. eCollection 2014.
4
Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.
Mol Ther. 2014 Aug;22(8):1450-1459. doi: 10.1038/mt.2014.84. Epub 2014 May 12.
5
6
Catalytic immunoglobulin gene delivery in a mouse model of Alzheimer's disease: prophylactic and therapeutic applications.
Mol Neurobiol. 2015 Feb;51(1):43-56. doi: 10.1007/s12035-014-8691-z. Epub 2014 Apr 15.
7
Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.
Nat Med. 2014 May;20(5):542-7. doi: 10.1038/nm.3510. Epub 2014 Apr 6.
8
Overcoming drug resistance in ALK-rearranged lung cancer.
N Engl J Med. 2014 Mar 27;370(13):1250-1. doi: 10.1056/NEJMe1316173.
9
Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure.
Gene Ther. 2014 Apr;21(4):379-386. doi: 10.1038/gt.2014.7. Epub 2014 Feb 27.
10
Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
Invest Ophthalmol Vis Sci. 2014 Mar 13;55(3):1519-30. doi: 10.1167/iovs.13-13155.
Zotero 插件